Biocon Ltd, in the pharma sector, witnessed a 40% decline from the December 2020 high but shows signs of a bullish trend. Traders are recommended to consider buying for target levels of 325-350. The daily Relative Strength Index (RSI) is at 65.0. RSI below 30 is oversold and above 70 is considered overbought, Trendlyne data showed.

Related Keywords

, Biocon Ltd , Trendlyne , Stock Radar , Relative Strength Index , Pharma Space , Momentum , Downward Sloping Channel , Biocon Share Price , Biocon , Analysis , 52 Week High ,